Literature DB >> 18037168

Delivering growth factors for therapeutics.

Eduardo Anitua1, Mikel Sánchez, Gorka Orive, Isabel Andia.   

Abstract

The method by which a drug is released can have a significant effect on therapeutic efficacy. The mode of drug delivery is especially relevant when the therapeutic agent is a growth factor because the dose and spatiotemporal release of such agents at the site of injury is crucial to achieving a successful outcome. Here, we highlight delivery technologies designed to facilitate the local and controlled spatiotemporal release of growth factors through the use of biomaterials, 3D micro- or nano-particles, microspheres, gene therapy and PRGF technology. We present some of the most interesting therapeutic applications based on these approaches and, on PRGF technology in particular, in addition to the limitations, future challenges and directions of the field.

Mesh:

Substances:

Year:  2007        PMID: 18037168     DOI: 10.1016/j.tips.2007.10.010

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  46 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Nanoparticulate systems for growth factor delivery.

Authors:  Sufeng Zhang; Hasan Uludağ
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

3.  Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications.

Authors:  Scott A Sell; Patricia S Wolfe; Jeffery J Ericksen; David G Simpson; Gary L Bowlin
Journal:  Tissue Eng Part A       Date:  2011-09-09       Impact factor: 3.845

Review 4.  Controlled delivery systems: from pharmaceuticals to cells and genes.

Authors:  Elizabeth Rosado Balmayor; Helena Sepulveda Azevedo; Rui L Reis
Journal:  Pharm Res       Date:  2011-03-19       Impact factor: 4.200

Review 5.  Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering.

Authors:  Asha Shekaran; Andres J Garcia
Journal:  Biochim Biophys Acta       Date:  2010-05-08

6.  Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid.

Authors:  E Anitua; M Sanchez; M De la Fuente; M M Zalduendo; G Orive
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-11       Impact factor: 4.342

7.  Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial.

Authors:  Lior Laver; Michael R Carmont; Mark O McConkey; Ezequiel Palmanovich; Eyal Yaacobi; Gideon Mann; Meir Nyska; Eugene Kots; Omer Mei-Dan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-18       Impact factor: 4.342

8.  Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing.

Authors:  Bruce W Han; Hans Layman; Nikhil A Rode; Anthony Conway; David V Schaffer; Nancy J Boudreau; Wesley M Jackson; Kevin E Healy
Journal:  Tissue Eng Part A       Date:  2015-09       Impact factor: 3.845

9.  Functional tissue engineering of ligament healing.

Authors:  Shan-Ling Hsu; Rui Liang; Savio Ly Woo
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-05-21

10.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.